Longitudinal follow-up of metformin treatment in Fragile X Syndrome

Longitudinal follow-up of metformin treatment in Fragile X Syndrome

IntroductionMetformin has been used as a targeted treatment to potentially improve cognition and slow the typical IQ decline that occurs during development among individuals with fragile X syndrome (FXS). In this follow-up study, we are following the trajectory of IQ and adaptive behavior changes ov...

Description complète

Détails bibliographiques
Auteurs principaux: Panhaneath Seng, Federica Alice Maria Montanaro, Hazel Maridith Barlahan Biag, Maria Jimena Salcedo-Arellano, Kyoungmi Kim, Matthew Dominic Ponzini, Flora Tassone, Andrea Schneider, Leonard Abbeduto, Angela John Thurman, David Hessl, Francois V. Bolduc, Sebastien Jacquemont, Sarah Lippé, Randi J. Hagerman
Format: Article
Langue:English
Publié: Frontiers Media S.A. 2024-06-01
Collection:Frontiers in Psychology
Sujets:
metformin
fragile X syndrome
treatment
IQ
adaptive behavior
longitudinal follow-up
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fpsyg.2024.1305597/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyg.2024.1305597/full

Documents similaires